Clinical Scorecard: Regulation of Gut Hormone Release by Calcium-Sensing Receptor Activity
At a Glance
Category
Detail
Condition
Regulation of gut hormone secretion affecting digestion, energy intake, and glycemia
Key Mechanisms
Activation of calcium-sensing receptor (CaSR) by extracellular Ca2+ and aromatic amino acids (L-tryptophan, L-phenylalanine) stimulates gut hormone release
Target Population
Individuals with obesity, type 2 diabetes, and healthy subjects
Care Setting
Clinical and research settings focusing on metabolic and gastrointestinal health
Key Highlights
CaSR expressed on enteroendocrine cells senses extracellular Ca2+ and aromatic amino acids to stimulate secretion of gut hormones including gastrin, CCK, GIP, GLP-1, and PYY.
Activation of CaSR by L-tryptophan and L-phenylalanine, enhanced by extracellular Ca2+, reduces energy intake and postprandial plasma glucose in preclinical and human studies.
CaSR modulators are clinically used for hypercalcemic disorders; nutrient-based activation of CaSR presents potential novel strategies for obesity and type 2 diabetes management.
Guideline-Based Recommendations
Diagnosis
Consider assessment of gut hormone responses in metabolic disorders related to energy intake and glycemic control.
Evaluate CaSR function in patients with calcium homeostasis disorders as it influences gut hormone secretion.
Management
Use CaSR positive allosteric modulators for hypercalcemic conditions such as primary and secondary hyperparathyroidism.
Explore dietary supplementation with Ca2+ and aromatic amino acids (L-Trp, L-Phe) to stimulate gut hormone release for appetite and glycemic regulation.
Investigate nutrient-based interventions targeting CaSR for obesity and type 2 diabetes treatment.
Monitoring & Follow-up
Monitor plasma levels of gut hormones (CCK, GLP-1, PYY) and postprandial glucose when implementing CaSR-targeted therapies or nutrient interventions.
Observe changes in energy intake and glycemic responses following CaSR activation strategies.
Risks
Potential risks related to inappropriate modulation of CaSR include disturbances in calcium homeostasis.
Limited human data on long-term effects of CaSR activation by nutrients necessitates cautious clinical application.
Patient & Prescribing Data
Patients with hypercalcemic disorders, obesity, and type 2 diabetes
CaSR positive allosteric modulators are established for hypercalcemia; nutrient-based CaSR activation shows promise in reducing energy intake and postprandial glycemia but requires further clinical validation.
Clinical Best Practices
Incorporate knowledge of CaSR’s role in gut hormone secretion when managing metabolic and calcium-related disorders.
Consider combined administration of extracellular Ca2+ with aromatic amino acids to potentiate gut hormone release and metabolic benefits.
Use CaSR modulators according to current indications and monitor for calcium balance and metabolic effects.
Support further research and clinical trials to establish efficacy and safety of nutrient-based CaSR activation in metabolic disease management.
